| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Prevention Division, National Cancer Center Research Institute, Tokyo 104 [M. S., H. F., H. F-S., S. Y.]; Laboratory of Molecular Oncology, Kanagawa Cancer Center Research Institute, Kanagawa 241 [S. Y.]; Faculty of Agriculture, University of Tokyo, Tokyo 113 [Y. K., N. F.]; and National Cancer Center, Tokyo 104 [T. S.], Japan
Calyculin A, isolated from a marine sponge, has a novel spiro ketal skeleton. Structurally unrelated to okadaic acid, calyculin A bound to the okadaic acid receptors in particulate and soluble fractions of mouse skin. The biochemical and tumor-promoting activities of calyculin A were studied with those of okadaic acid. Calyculin A inhibited the activity of protein phosphatases, which serve as the okadaic acid receptors. The effective dose of calyculin A for 50% inhibition was 0.3 nM, similar to that of okadaic acid. Like okadaic acid, calyculin A induced ornithine decarboxylase in mouse skin and hyperphosphorylation of a Mr 60,000 protein in human papilloma virus type 16-transformed human keratinocytes. A two-stage carcinogenesis experiment on mouse skin, initiated by 100 µg (390 nmol) of 7,12-dimethylbenz(a)anthracene and followed by 1 µg (1.0 nmol) of calyculin A, revealed that calyculin A is an additional member of the okadaic acid class of tumor promoters. The percentages of tumor-bearing mice in the groups treated with DMBA plus calyculin A, and with DMBA followed by 1 µg (1.2 nmol) of okadaic acid were 86.7 and 80.0%, respectively, in week 30. The mechanisms of action of calyculin A and okadaic acid, in addition to dinophysistoxin-1 (35-methylokadaic acid), are discussed. Calyculin A is the first tumor promoter to be screened by the okadaic acid receptor binding test.
1 This work was supported in part by Grants-in-Aid for Cancer Research from the Ministry of Education, Science and Culture and the Ministry of Health and Welfare, for a Comprehensive 10-Year Strategy for Cancer Control, Japan, and the Princess Takamatsu Cancer Research Fund.
2 To whom requests for reprints should be addressed.
Received 10/ 3/89.
Revised 2/12/90.
This article has been cited by other articles:
![]() |
H. Buss, A. Dorrie, M. L. Schmitz, R. Frank, M. Livingstone, K. Resch, and M. Kracht Phosphorylation of Serine 468 by GSK-3{beta} Negatively Regulates Basal p65 NF-{kappa}B Activity J. Biol. Chem., November 26, 2004; 279(48): 49571 - 49574. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. McCready, B. F. Islam, F. J. Schmitz, H. A. Luu, J. F. Dawson, and C. F. B. Holmes Inhibition of Protein Phosphatase-1 by Clavosines A and B. NOVEL MEMBERS OF THE CALYCULIN FAMILY OF TOXINS J. Biol. Chem., February 11, 2000; 275(6): 4192 - 4198. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Srivastava and H. B. Pollard Molecular dissection of nucleolin's role in growth and cell proliferation: new insights FASEB J, November 1, 1999; 13(14): 1911 - 1922. [Abstract] [Full Text] |
||||
![]() |
T. Blank, I. Nijholt, U. Teichert, H. Kugler, H. Behrsing, A. Fienberg, P. Greengard, and J. Spiess The phosphoprotein DARPP-32 mediates cAMP-dependent potentiation of striatal N-methyl-D-aspartate responses PNAS, December 23, 1997; 94(26): 14859 - 14864. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.A. Barber, C.A. Salkowski, M.J. Fultz, P-Y. Perera, R. McNally, and S.N. Vogel Regulation of gene expression and nitric oxide production in murine macrophages by the serine/threonine phosphatase inhibitor okadaic acid Innate Immunity, February 1, 1996; 3(1): 19 - 27. [Abstract] [PDF] |
||||
![]() |
R. Mulkey, C. Herron, and R. Malenka An essential role for protein phosphatases in hippocampal long-term depression Science, August 20, 1993; 261(5124): 1051 - 1055. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |